CV Lattes
Universidade Estadual Paulista (UNESP). Campus de Araraquara. Faculdade de Ciências Farmacêuticas (FCFAR) (Institutional affiliation from the last research proposal) Birthplace: Brazil
Ana Carolina Kogawa has degree in Pharmacy-Biochemistry (2008), Master (2012), PhD (2015) and Post Doctorate (2019) in Pharmaceutical Sciences at Universidade Estadual Paulista - UNESP. She has Lean Manufacturing, Black Belt and Power BI training with knowledge of quality tools: 5S's, 5W and 2H, 6 sigma, Benchmarking, Brainstorming, Control Charts, FMEA, Ishikawa Diagram, Multi vote, Pareto chart, Poka Yoke, Mapping process, SWOT Analysis, the 5 whys, Table Pairs, Team Charter, Balanced Scorecard, MGPP, Table RACI, Johari Window, MSA, Design of Experiments, Design for Six Sigma, Force Field Analysis, APQP, Quick Win . Experience in managing people and projects, coordinating activities in the All Pharma Jr., Noxon do Brasil Química Farmacêutica and UNESP. Teaching experience obtained in ministering personnel training in All Pharma Jr., JP Industria Farmacêutica and pre-university courses at Curso Unificado do Campus de Araraquara. She has experience of activities in the industrial sector in the Drugs and Medicines, with emphasis on Quality Control both physicochemical and microbiological, obtained from the Medley and JP Industria Farmacêutica. She is currently Professor at the Faculty of Pharmacy of the Federal University of Goiás. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Rifaximin is an oral antimicrobial, intestine-selective, with low level of selection for resistant bacterial mutations and not systemic with adverse effects compared to placebo. It is used for the treatment of hepatic encephalopathy, travelers' diarrhea, irritable bowel syndrome, Clostridium difficile, ulcerative colitis and acute diarrhea. On the market rifaximin tablets of 200 mg under …
Darunavir is a protease inhibitor used in the treatment of HIV infection. It is a synthetic non-peptide analogue of amprenavir which became commercially available in 2006. It is a pillar of the therapy cocktail for patients with the virus. On the market are found Darunavir ethanolate tablets of 75, 300, 400 and 600 mg. This is the most stable form. This drug has low solubility in water an…
The doxycycline hyclate is a broad-spectrum antibiotic derived from oxytetracycline used in several countries. It has been used to treat infectious diseases and as an additive in animal feed to facilitate their growth. In Brazil this drug is marketed by Union Chemical pharmaceutical dosage form in 80mg and 200mg tablets with the name Doxitrat ® and 10ml vial with the name Calmium ®, since…
Rifaximin is an oral antimicrobial, intestine - selective, with low level selection for mutations of resistant bacteria and no systemic with adverse effects compared to placebo. It is used for the treatment of hepatic encephalopathy, travelers' diarrhea, syndrome of irritable bowel, Clostridium difficile, ulcerative colitis and acute diarrhea. Rifaximin has low solubility in water, theref…
Rifaximin is an oral antimicrobial, intestine - selective, with low level selection for mutations of resistant bacteria and no systemic with adverse effects compared to placebo. It is used for the treatment of hepatic encephalopathy, travelers' diarrhea, syndrome of irritable bowel, Clostridium difficile, ulcerative colitis and acute diarrhea. The rifaximin, until then, has no standardize…
| 3 / 3 | Completed scholarships in Brazil |
| 2 / 2 | Completed scholarships abroad |
| 5 / 5 | All Scholarships |
| Associated processes | |